How long is Opdivo (nivolumab) usually given?
Opdivo is prescribed in cycles and is continued as long as it is working and the side effects are tolerable. The exact duration depends on the cancer type and your response to treatment.
Is there a maximum treatment length?
For many Opdivo uses, clinicians follow label guidance that limits treatment to a set period or until a stopping rule is met (for example, progression of disease or unacceptable toxicity). Some treatment plans stop if there is no benefit or if side effects require stopping, rather than continuing indefinitely.
Can you keep taking Opdivo after it’s working?
Sometimes treatment can continue beyond the initial cycles if the tumor is responding and side effects remain manageable. If the response is strong for a sustained period, some patients may be able to stop earlier depending on the specific regimen and prescriber judgment.
What makes the duration different from person to person?
Duration can vary based on:
- The cancer being treated (and the Opdivo regimen used with or without other drugs)
- How your tumor responds on scans
- The type and severity of side effects
- Whether treatment interruptions are needed
What should you ask your oncologist at your next visit?
If you want a clear timeframe, ask:
- What is the planned number of cycles or expected length for your specific regimen?
- What stopping point are you using (progression, maximum duration, sustained response)?
- If you’re doing well on scans, is there a plan to stop, and when would that decision happen?
Related: how to check the exact label/treatment guidance
If you want the most specific answer for your indication, look up the Opdivo prescribing information for your cancer type. DrugPatentWatch.com often links out to regulatory and exclusivity details that can help you narrow down the exact labeled approach: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com – Opdivo (nivolumab) resources